Uniphos Enterprises Limited
Valuation (73/100) does the heavy lifting; financial trend (0/100) is the drag.
Fair valueUniphos Enterprises Limited earns a Sell from StocksWizard, with a blended score of 36/100. We put fair value near ₹189.84; at ₹94.92 that leaves roughly 100% upside, so the stock screens undervalued by 100%. On 37.1x trailing earnings it sits pricier than the Basic Materials median of about 22.2x. The price is about 39% below its 52-week high of ₹154.68 and 9% above the low of ₹86.92. Financial health scores 45/100, in the grey band on the Altman Z-score, with a Piotroski F-score of 0/9. It clears 4 of 11 investability checks, with durability 38, valuation 46 and momentum 12 on our 0–100 scales.
Analysis by Ankit Sharma · StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹151.87. Low-confidence estimate — limited data.
1-year price
EOD · 2026-07-3152-week range
-38.64% from the 52-week high.
Price above both moving averages reads as an intact uptrend; below both, the trend is against you.
Verdict pillars
Sell36Piotroski F-score 0/9 — quality of earnings & balance sheet.
Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Investability checklist
- Fail: ROE above 15%: 0.8%
- No data: Low debt (D/E < 0.5)
- Fail: Positive free cash flow
- Fail: Revenue growth > 10%: -64%
- No data: Earnings growing
- Pass: Net margin ≥ 10%: 64.7%
- Pass: Current ratio > 1.5: 1.68
- Pass: Below our fair value
- Pass: Margin of safety ≥ 20%
- Fail: Above 200-day average
- Fail: Above 50-day average
- No data: Positive 1-year return
- Fail: Altman Z in safe zone: Z 2.8
- Fail: Piotroski ≥ 7: 0/9
Annual financials
Shareholding
- Promoter79.3%
- Institutions10.6%
- Public & other10.1%
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
Bull case vs bear case
Bull case
Strengths
- Healthy profit margin (64.7%).
Opportunities
- Well off its 52-week high — possible mean-reversion.
- Trades ~100% below our estimated fair value.
Bear case
Weaknesses
- Low return on equity (0.8%).
- Price below its 200-day moving average (downtrend).
- Weak Piotroski score (0/9).
About Uniphos Enterprises Limited
Uniphos Enterprises Limited trades chemicals and agro commodities within India and holds investments in securities and mutual funds. Incorporated in 1969, the company operates from Mumbai.
Uniphos Enterprises Limited — frequently asked questions
Is Uniphos Enterprises Limited a buy, hold or sell?
StocksWizard currently rates Uniphos Enterprises Limited (UNIENTER) a Sell, based on a blended score of 36/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.
What is Uniphos Enterprises Limited's fair value?
Our blended DCF and relative-valuation model estimates Uniphos Enterprises Limited's fair value at about ₹189.84, versus a current price of ₹94.92 — roughly 100% upside. On that basis the stock looks undervalued by 100%.
Is Uniphos Enterprises Limited financially healthy?
Uniphos Enterprises Limited scores 45/100 on our financial-health model, placing it in the grey band on the Altman Z-score, with a Piotroski F-score of 0/9.
How has Uniphos Enterprises Limited's share price performed?
Uniphos Enterprises Limited is down 7% over three months, and last traded at ₹94.92. Past performance doesn't predict future returns.
More in Basic Materials
View allOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.